Genomic impact of transient low-dose decitabine treatment on primary AML cells.
Klco JM, Spencer DH, Lamprecht TL, Sarkaria SM, Wylie T, Magrini V, Hundal J, Walker J, Varghese N, Erdmann-Gilmore P, Lichti CF, Meyer MR, Townsend RR, Wilson RK, Mardis ER, Ley TJ.
Klco JM, et al. Among authors: lichti cf.
Blood. 2013 Feb 28;121(9):1633-43. doi: 10.1182/blood-2012-09-459313. Epub 2013 Jan 7.
Blood. 2013.
PMID: 23297133
Free PMC article.